<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0110">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Stopeck</surname>
    <given-names>AT</given-names>
   </name>, 
   <name name-style="western">
    <surname>Fizazi</surname>
    <given-names>K</given-names>
   </name>, 
   <name name-style="western">
    <surname>Body</surname>
    <given-names>JJ</given-names>
   </name>, 
   <etal>et al.</etal>
  </person-group> (
  <year>2016</year>). 
  <article-title>Safety of long-term denosumab therapy: results from the open label extension phase of two phase 3 studies in patients with metastatic breast and prostate cancer</article-title>. 
  <source>Support Care Cancer</source>
  <volume>24</volume>:
  <fpage>447</fpage>–
  <lpage>55</lpage>.
  <pub-id pub-id-type="pmid">26335402</pub-id>
 </mixed-citation>
</ref>
